ArticleCureus2025

Tumor Lysis Syndrome Induced by Selpercatinib in Rearranged During Transfection (RET) Fusion-Positive Non-Small-Cell Lung Cancer.

Shinobu Sagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.